129 related articles for article (PubMed ID: 36316144)
1. A Tale of 2 Countries: Implementation of the Cold Chain Equipment Optimization Platform in Guinea and Kenya.
Stammer E; Teklemariam L; Barry A; Millimono R; Chweya A; Danfakha N; Golia C; Herrera E; Patykewich L; Prosser W; Alva S
Glob Health Sci Pract; 2022 Oct; 10(5):. PubMed ID: 36316144
[TBL] [Abstract][Full Text] [Related]
2. Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy.
Prosser W; Sagar K; Seidel M; Alva S
BMC Health Serv Res; 2022 Oct; 22(1):1237. PubMed ID: 36207724
[TBL] [Abstract][Full Text] [Related]
3. Seizing market shaping opportunities for vaccine cold chain equipment.
Azimi T; Franzel L; Probst N
Vaccine; 2017 Apr; 35(17):2260-2264. PubMed ID: 28364940
[TBL] [Abstract][Full Text] [Related]
4. Deployment of vaccine cold chain equipment in resource-limited settings: lessons from the Gavi Cold Chain Optimization Platform in Cameroon.
Nkwain J; Zambou VM; Nchinjoh SC; Agbor VN; Adidja A; Mbanga C; Edwidge NN; Ndoula ST; Andreas AN; Diack D; Di Mattei P; Wiwa O; Diaby O; Saidu Y
Int Health; 2024 Feb; ():. PubMed ID: 38333954
[TBL] [Abstract][Full Text] [Related]
5. Perspective and investments in health system strengthening of Gavi, the Vaccine Alliance: a content analysis of health system strengthening-specific funding.
Tsai FJ; Lee H; Fan VY
Int Health; 2016 Jul; 8(4):246-52. PubMed ID: 26612851
[TBL] [Abstract][Full Text] [Related]
6. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
[TBL] [Abstract][Full Text] [Related]
7. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
[TBL] [Abstract][Full Text] [Related]
8. Pro-equity immunization and health systems strengthening strategies in select Gavi-supported countries.
Dadari I; Higgins-Steele A; Sharkey A; Charlet D; Shahabuddin A; Nandy R; Jackson D
Vaccine; 2021 Apr; 39(17):2434-2444. PubMed ID: 33781603
[TBL] [Abstract][Full Text] [Related]
9. Tracking donor funding towards achieving the Global Vaccine Action Plan (GVAP) goals: A landscape analysis (1990-2016).
Ikilezi G; Zlavog B; Augusto OJ; Sherr K; Lim SS; Dieleman JL
Vaccine; 2018 Nov; 36(49):7487-7495. PubMed ID: 30366804
[TBL] [Abstract][Full Text] [Related]
10. Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.
Mvundura M; Lorenson K; Chweya A; Kigadye R; Bartholomew K; Makame M; Lennon TP; Mwangi S; Kirika L; Kamau P; Otieno A; Murunga P; Omurwa T; Dafrossa L; Kristensen D
Vaccine; 2015 May; 33(23):2697-703. PubMed ID: 25865467
[TBL] [Abstract][Full Text] [Related]
11. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
12. Gavi's policy steers country ownership and self-financing of immunization.
Henderson K; Gouglas D; Craw L
Vaccine; 2016 Aug; 34(37):4354-9. PubMed ID: 27431423
[TBL] [Abstract][Full Text] [Related]
13. Improving cold chain systems: Challenges and solutions.
Ashok A; Brison M; LeTallec Y
Vaccine; 2017 Apr; 35(17):2217-2223. PubMed ID: 27670076
[TBL] [Abstract][Full Text] [Related]
14. Root cause analysis underscores the importance of understanding, addressing, and communicating cold chain equipment failures to improve equipment performance.
Lennon P; Atuhaire B; Yavari S; Sampath V; Mvundura M; Ramanathan N; Robertson J
Vaccine; 2017 Apr; 35(17):2198-2202. PubMed ID: 28364931
[TBL] [Abstract][Full Text] [Related]
15. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
16. Challenges to implementing Gavi's health system strengthening support in Chad and Cameroon: results from a mixed-methods evaluation.
Dansereau E; Miangotar Y; Squires E; Mimche H; ; ; El Bcheraoui C
Global Health; 2017 Nov; 13(1):83. PubMed ID: 29145871
[TBL] [Abstract][Full Text] [Related]
17. Resource Allocation Strategies to Increase the Efficiency and Sustainability of Gavi's Health System Strengthening Grants.
Mimche H; Squires E; Miangotar Y; Mokdad A; El Bcheraoui C; ;
Pediatr Infect Dis J; 2018 May; 37(5):407-412. PubMed ID: 29278610
[TBL] [Abstract][Full Text] [Related]
18. Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.
Malhame M; Baker E; Gandhi G; Jones A; Kalpaxis P; Iqbal R; Momeni Y; Nguyen A
Vaccine X; 2019 Aug; 2():100033. PubMed ID: 31384748
[TBL] [Abstract][Full Text] [Related]
19. The origins of the vaccine cold chain and a glimpse of the future.
Lloyd J; Cheyne J
Vaccine; 2017 Apr; 35(17):2115-2120. PubMed ID: 28364918
[TBL] [Abstract][Full Text] [Related]
20. Transforming vaccines supply chains in Nigeria.
Sarley D; Mahmud M; Idris J; Osunkiyesi M; Dibosa-Osadolor O; Okebukola P; Wiwa O
Vaccine; 2017 Apr; 35(17):2167-2174. PubMed ID: 28364926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
